India Hemostat Market to reach US$ 105.1 million by 2027 | CAGR: 5.4%: Coherent Market Insights
Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
A hemostat is used in both minor and major surgeries, primarily in orthopedic and cardiac cases where there is extensive blood flow once incisions are made. Hemostats are also used in excision, amputations, emergency surgeries, and other such procedures.
Get FREE Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-pdf/3524
In 2018, the India hemostat market was valued at US$ 63.1 million and is expected to reach US$ 105.1 million by 2027.
India Hemostat Market: Drivers
Growth of the India hemostat market is expected to be driven by the increasing number of hospitals and healthcare facilities and surge in healthcare expenditure. According to the Ministry of Health and Family Welfare, Government of India, the number of government hospitals in India increased from 35,416 in 2017 to 37,725 in 2018.
India Hemostat Market: Opportunities
The growing medical tourism sector is expected to provide significant growth opportunities to key players. For instance, according to the India Brand Equity Foundation’s January 2019 release, the estimated Foreign Tourist Arrivals (FTAs) in India on medical purposes during 2015, 2016, and 2017 were 233,918, 427,014, and 495,056 respectively.
Browse Press Release: https://www.coherentmarketinsights.com/press-release/india-hemostat-market-2846
India Hemostat Market: Restraints
The low doctor-patient ratio is expected to hamper the India hemostat market growth. For example, according to the World Health Organization’s (WHO’s) data updated in April 2019, in India, there is one government doctor for every 10,189 people or a deficit of 600,000 doctors, and the nurse: patient ratio is 1:483.
Key Takeaways:
Based on the product form, the mechanical segment dominated the India hemostat market in 2018, accounting for 88.8% of the market share in terms of value. Moreover, the segment is expected to witness lucrative growth as it is the primary hemostatic technique employed in hospitals. Mechanical hemostatic techniques such as the use of staples, sutures, and ligating clips are cost-effective.
In 2018, the surgeries segment dominated the India hemostat market, accounting for 63.1% of the market share in terms of value, followed by the trauma cases segment. Moreover, the growth of the segment is expected to be driven by the increasing number of surgical procedures in both domestic and international patients. For example, in 2018, the All India Institute of Medical Science (AIIMS) performed ~0.2 million surgeries.
Apply Promo Code “STAYHOME” And Get an Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/3524
In 2018, the hospital segment dominated the India hemostat market in 2018, accounting for 40.9% of market share in terms of value, followed by the ambulatory surgical centers and clinics segment. Moreover, the growth of the segment is expected to be driven by the increasing healthcare investment and reimbursement facilities. For example, the government of India approved the continuation of the National Health Mission with a budget of US$ 4.40 billion under the Union Budget 2019-20. Furthermore, Ayushman Bharat – Pradhan Mantri Jan Arogya Yojana (PMJAY), the largest government-funded healthcare program targeting more than 500 million beneficiaries, has been allocated US$ 887.04 million under the Union Budget 2019-20.
Market Trends:
Local players in the market are focused on expanding their business in developed markets. For example, in March 2018, Axio Biosolutions Private Limited, an India-based medical device manufacturer, received the U.S. FDA clearance for its Axiostat chitosan hemostatic dressing.
Key players are focused on distributing their products through online platforms to increase their market share. For instance, Ethicon Inc., a subsidiary of Johnson & Johnson, offers Ethicon Surgicel absorbable hemostat and other products on various e-commerce platforms.
India Hemostat Market: Competitive Landscape
Major players operating in India hemostat market are Ethicon Inc., Aegis Lifesciences. Eucare Pharmaceuticals (P) Ltd., Baxter International, Axio Biosolutions Private Limited, and Mil Laboratories.
India Hemostat Market: Key Developments
Key players are focused on expanding their manufacturing facilities. For example, in April 2019, Axio Biosolutions Private Limited expanded its state-of-the-art manufacturing facility at Gujarat Pharma Techno Park in Ahmedabad, India.
Special Requirements?
We value your investment and offer customization as per your requirements.
Share your precise requirements @ https://www.coherentmarketinsights.com/insight/request-customization/3524
Key players are engaged in strategic mergers and acquisitions to expand their product portfolio. For example, in March 2018, Baxter International closed the US$ 153 million acquisition of hemostat and sealant assets from Mallinckrodt Pharmaceuticals.
Segmentation
- By Product Form
- Mechanical
- Flowable
- By Product Base
- Gelatin
- Cellulose
- By Application
- Surgeries
- Trauma Cases
- By End-User
- Hospitals
- Ambulatory Surgical Centers
- Clinics
View Press Release For More Information @
About Us:Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at contact@cdnnewswire.com.
Editor Details
-
Company:
- CDN Newswire
